This inventor holds 1 USPTO granted patent. Top assignee: Korea Institute of Science and Technology. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Hyemyung Seo: Innovator in Histone Methyltransferase Inhibition
Introduction
Hyemyung Seo is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of compounds that target histone methyltransferases.
Latest Patents
Hyemyung Seo holds a patent for "Quinoline derivatives for inhibiting histone methyltransferases and use thereof." This patent describes a quinoline derivative that inhibits the activity of histone methyltransferases, specifically ESET/SETDB1, which is crucial for the histone molecule H3K9. The invention also includes pharmaceutically acceptable salts of the compound and outlines its potential applications in therapeutic settings.
Career Highlights
Hyemyung Seo is affiliated with the Korea Institute of Science and Technology, where he conducts research and development in the field of medicinal chemistry. His work focuses on creating innovative solutions for complex biological problems.
Collaborations
Hyemyung Seo collaborates with notable colleagues, including Hyunah Choo and Sun-Joon Min, to advance research in his field. Their combined expertise contributes to the success of their projects and the development of new therapeutic strategies.
Conclusion
Hyemyung Seo's innovative work in histone methyltransferase inhibition showcases his dedication to advancing medical science. His contributions are paving the way for new treatments and understanding of epigenetic regulation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile